• PIH6 Unintentional Exposures to Buprenorphine/Naloxone Tablets and Oral Film among Children Less Than Six Years Old

    Nov 1, 2012, 00:00

  • PHP194 Why Do Patients Engage in Medical Tourism?

    Nov 1, 2012, 00:00

  • PRM129 Final Reports for Translation and Linguistic Validation of Clinical Outcome Assessments

    Nov 1, 2012, 00:00

  • PHS66 Outcomes and Determinants of Caregiver Burden After First-Ever Stroke- The Erlangen Stroke Project (ESPRO)

    Nov 1, 2012, 00:00

  • PGI5 Effectiveness and Safety of Antacids in Pregnant Women Suffering From Gerd/Hyperacidity Symptoms

    Nov 1, 2012, 00:00

  • PIN73 Direct Medical Costs and Health Care Resource Use Associated With Hepatis C Infection in Portugal

    Nov 1, 2012, 00:00

  • PMH18 Treatment Patterns and Costs in Patients With Schizophrenia in Germany

    Nov 1, 2012, 00:00

  • CE2 Cost-Effectiveness of the Real-World Use of Nucleic Acid Test Screening to Donated Blood for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus- Experience From Taiwan, a Country With a High Prevalence of Hepatitis B and C Infec ...

    Nov 1, 2012, 00:00

  • PUK24 Pharmacoeconomic Aspects of Use of Erythropoietin Drugs in Patients on Hemodialysis in Ukraine

    Nov 1, 2012, 00:00

  • PCV10 Analysis of Consumption of ACE Inhibitors Funded by Republic Fund of Health Insurance of the Serbia in 2009

    Nov 1, 2012, 00:00

  • PIN32 Economic Evaluation of Boceprevir for the Treatment of Patients With Genotype 1 Chronic Hepatitis C Virus Infection in Hungary

    Nov 1, 2012, 00:00

  • PRM84 Using Proportional Hazard Models to Predict Price Changes of Oncology Drugs in the United States

    Nov 1, 2012, 00:00

  • PDB62 Type 2 Diabetes in Russia- Prevalence, Risk Factors, and Burden

    Nov 1, 2012, 00:00

  • PHP29 Considerable Differences in the Utilization of Antidepressants Between Serbia and Denmark

    Nov 1, 2012, 00:00

  • PRS3 Real World Effectiveness and Relative Effectiveness of Omalizumab. An Historic-Prospective Design Study

    Nov 1, 2012, 00:00

  • PHS21 Out-of-Pocket Financial Burden in Atrial Fibrillation and Potential Impact on Care- Comparison Across Five European Countries Using the European Patient Survey in Atrial Fibrillation (EUPS-AF)

    Nov 1, 2012, 00:00

  • PCN5 Impact of Erythropoiesis Stimulating Agents on Survival among Patinets With Colorectal Cancer Receiving Chemotherapy

    Nov 1, 2012, 00:00

  • PMS27 The Method for Reversing Anticoagulation Affects Treatment Costs and May Decrease Mortality Among Hip Fracture Patients Using Warfarin

    Nov 1, 2012, 00:00

  • PCV112 Dosage Analysis of CHF Therapies on the Basis of Hungarian Claim Database

    Nov 1, 2012, 00:00

  • PCV8 Evaluation of Efficacy and Safety of Antihypertensive Drugs on the Reimbursement List for Delisting Policy in Korea

    Nov 1, 2012, 00:00

  • PHP78 System-Wide Impact of Payment Schemes for Integrated Care of Chronic Diseases in Europe- Evidence from an Empirical Analysis

    Nov 1, 2012, 00:00

  • PCV89 Experience Sampling to Obtain Health State Valuations

    Nov 1, 2012, 00:00

  • PGI40 Physician-Initiated Treatment Patterns of Ulcerative Colitis (UC) Patients in the UK- a Review of Chart-Abstracted Data

    Nov 1, 2012, 00:00

  • PSU9 Budget Impact of Autograft Harvest, Bone Graft Supplements and Orthobiologic Bone Graft Substitute in Foot and Ankle Fusion Procedures

    Nov 1, 2012, 00:00

  • PSS31 Prevalence of Chronic Wounds in Germany — a Secondary Data Analysis

    Nov 1, 2012, 00:00

  • PDB78 Determinants of Treatment Changes of Oral Anti/Diabetic Drugs in the UK

    Nov 1, 2012, 00:00

  • PHP30 Using Nationwide Administrative Data to Evaluate Generic Drug Pricing and Physician Prescription

    Nov 1, 2012, 00:00

  • PIH11 Cost of Unintended Pregnancy in the UK- A Role for Increased Use of Long-Acting Reversible Contraceptive Methods

    Nov 1, 2012, 00:00

  • PHP146 Pharmacoeconomic Education for Pharmacy Students in the Russian Federation

    Nov 1, 2012, 00:00

  • PHS4 Epidemiology and Control of Tuberculosis in Ooty

    Nov 1, 2012, 00:00

  • PCV118 Fixed-Dose Combinations and Their Value to Payers

    Nov 1, 2012, 00:00

  • PHP171 HTA Principles Inclusion in New European Union Member States

    Nov 1, 2012, 00:00

  • PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity

    Nov 1, 2012, 00:00

  • PDB54 Systematic Literature Review of Utility Values Associated With Type 2 Diabetes-Related Complications

    Nov 1, 2012, 00:00

  • PCN21 Melody Brasil- Real World Health Outcomes of the Treatment of Metastatic Melanoma Patients in the Brazilian Health System

    Nov 1, 2012, 00:00

  • PMD15 Budget Impact Analysis of Vascular Closure Devices (VCDs) in Italy and Spain

    Nov 1, 2012, 00:00

  • PCN64 Cost-Consequence Analysis (CCA) of the Treatment of Growing Subependymal Giant Cell Astrocytoma (SEGA) Secondary to Tuberous Sclerosis Complex (TSC) in Brazil

    Nov 1, 2012, 00:00

  • PIN58 Cost Per Sustained Virological Response of Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients According to the Previous Treatment Response and the Metavir Groups in Brazil

    Nov 1, 2012, 00:00

  • PMD32 Outcomes and Costs of Isolated Aortic Valve Replacements Associated With the Mini-Invasive Implantation of a New Sutureless and Collapsed Valve in Italy, France, Germany, and UK

    Nov 1, 2012, 00:00

  • PRM73 The Use of Cumulative Hazard Plots to Inform Resource Allocation and Research Decisions in Health Care

    Nov 1, 2012, 00:00

  • PHP87 Satisfaction Assessment of Insurance System for Urban Residents (URMS) of University Students in Shenyang

    Nov 1, 2012, 00:00

  • PRS22 Cost-Effectiveness of Beclomethasone/Formoterol Versus Fluticasone/Salmeterol in the Treatment of Patient With Moderate to Severe Asthma in Spain

    Nov 1, 2012, 00:00

  • PSY33 Item Reduction and Assessment of Measurement Properties of the Hunter Syndrome – Functional Outcomes for Clinical Understanding Scale (HS-FOCUS)

    Nov 1, 2012, 00:00

  • PRS16 Socioeconomic Burden of COPD in Ukraine- 2012-2020 Perspective Modeling

    Nov 1, 2012, 00:00

  • PRM27 Evaluating European Data Sources for Assessing Real-World Effectiveness of New Anti-Diabetic Drugs

    Nov 1, 2012, 00:00

  • PRM112 Recruitment Costs and Efficiency Varies With Condition/ Patient Population

    Nov 1, 2012, 00:00

  • PRM4 Assessment of Immunosuppressive Therapies for Renal Transplantation - Criteria Considered for Evaluation by the EMA, European HTA Agencies and the German IQWiG

    Nov 1, 2012, 00:00

  • PIN8 Assessment of Tuberculosis Burden in China Using a Dynamic Disease Simulation Model

    Nov 1, 2012, 00:00

  • PCN148 Review of National Institute for Health and Clinical Excellence (NICE) Recommendations for Anti-Cancer Agents Across Multiple Drug-Indication Combinations

    Nov 1, 2012, 00:00

  • PDB26 Evidence Requirements in Australia for Drug Reimbursement- The Survival of Cost Minimisation Analysis

    Nov 1, 2012, 00:00

  • PHS70 Health Related Quality of Life As Predictor of Death Among Patients With Heart Failure

    Nov 1, 2012, 00:00

  • PUK23 Burden of Chronic Kidney Disease in German Diabetes Patients, a Systematic Literature Review and Data Gap Analysis

    Nov 1, 2012, 00:00

  • PHP203 How to Optimise Chances for Successful AMNOG Assessments – Best Practice Approach for German Market Access

    Nov 1, 2012, 00:00

  • PMH19 A Rehabilitation Intervention to Help People With Severe Mental Illness Obtain and Keep a Paid Job- The Economic Evaluation

    Nov 1, 2012, 00:00

  • PIN4 Mixed-Treatment Comparison of the Efficacy and Safety of Antiretroviral Drugs Indicated for Treatment-Experienced HIV Patients

    Nov 1, 2012, 00:00

  • PCN61 Melody Brazil – Resource Use and Associated Costs With Metastatic Melanoma in Brazilian Health Care System

    Nov 1, 2012, 00:00

  • PCN17 Indirect Comparison of the Efficacy of Erlotinib Versus Pemetrexed Plus Cisplatin as First Line Treatment in Patients With Metastatic Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor Activating Mutations

    Nov 1, 2012, 00:00

  • PDB31 The Prevalence and Burden of Comorbid Hypertension and Obesity Among Patients With Type 2 Diabetes in Urban China

    Nov 1, 2012, 00:00

  • PMD68 Cost-Effectiveness of Sacral Neuromodulation in the Treatment of Idiopathic Wet Refractory Overactive Bladder in Italy

    Nov 1, 2012, 00:00

  • PRM135 Validity, Reliability and Responsiveness of the Spanish Minnesota Living With Heart Failure Questionnaire

    Nov 1, 2012, 00:00

  • PND60 Non-Diabetic Peripheral Neuropathic Pain is Underdiagnosed in GP Practices Although it has High Impact on Patients' Health Related Quality of Life

    Nov 1, 2012, 00:00

  • PCV16 Use of ACE Inhibitors in Serbia in 2009 and 2010

    Nov 1, 2012, 00:00

  • HC1 Price Premium for Innovation? Cost Calculation Method in Japan Versus Cost Utility Analysis in South Korea

    Nov 1, 2012, 00:00

  • PCN33 Health Related Quality of Life in Post-Operative Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PMD44 Evaluating Strategies for Using DNA Testing to Identify Mucinous Pancreatic Cysts

    Nov 1, 2012, 00:00

  • PHP31 The Value of Investigational Medical Products

    Nov 1, 2012, 00:00

  • PCN8 Axitinib (AXI) and Best Supportive Care (BSC) in the Treatment of Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma (mRCC)- Results of a Simulated Treatment Comparison (STC) Analyses

    Nov 1, 2012, 00:00

  • PHP47 Impact of Economic and Policy Factors on China'S Health Care Expenditure

    Nov 1, 2012, 00:00

  • PCV110 Multivariate Analysis of Clinical and Patient-Level Factors Associated With Colesevelam Treatment Persistence

    Nov 1, 2012, 00:00

  • PIH2 Duloxetine Use in Pregnancy- A Prospective, Comparative Study of Exposed Infants

    Nov 1, 2012, 00:00

  • PCN16 Clinical Effectiveness Analysis of Sunitinib for the Treatment of Pancreatic Neuroendocrine Tumors

    Nov 1, 2012, 00:00

  • PHP2 Economic Cost Savings of Technological Improvement for Lower-Level Hospitals- A Pilot Study in China

    Nov 1, 2012, 00:00

  • PCN53 Real World Management and Costs in Metastatic Malignant Melanoma (MM) Patients- A Pilot Study Based on an Institutional Patient Registry

    Nov 1, 2012, 00:00

  • PHP68 The Effect of Resetting the Clock in Health Care

    Nov 1, 2012, 00:00

  • PHP65 Perceptions Among General Medical Practitioners Towards Implementation of Medication Reconciliation Program for Patients Discharged from Hospitals in Penang, Malaysia

    Nov 1, 2012, 00:00

  • PHP7 Health Care Decision Making in Mainland China, Korea, and Taiwan- The Road Ahead?

    Nov 1, 2012, 00:00

  • PHS51 Hospital Stays of Multiple Sclerosis Patients in Germany – Reasons, Frequencies, Duration and Impact on Drug Therapy

    Nov 1, 2012, 00:00

  • PUK2 Issues in the Systematic Review of Drugs for Rare Diseases- A Case Study of Eculizumab for aHUS

    Nov 1, 2012, 00:00

  • PHP18 The Effect of Law for Economical Use of Medications 2006 on the Catchment Population of Community Pharmacies Between 2007-2010

    Nov 1, 2012, 00:00

  • PMD9 A Comparative Assessment of Cost Implications of Novel Drug Versus Novel Device-Based Treatments for Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PRM26 Comparison of Three Medication Adherence Measures in Patients Taking Warfarin

    Nov 1, 2012, 00:00

  • PHS13 Costs Analysis of a Mobile Phone Telemonitoring System for Glycaemic Control in Patients With Diabetes Mellitus (DM) in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PCN137 NICE Technology Appraisals and the Uptake of Breast Cancer Drugs in the UK

    Nov 1, 2012, 00:00

  • PMS18 Impact of Etanercept-Methotrexate Therapy on Patient-Reported Outcomes in Moderately Active Rheumatoid Arthritis (RA) Patients of Europe, Latin America, and Asia

    Nov 1, 2012, 00:00

  • PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in Finland

    Nov 1, 2012, 00:00

  • PND69 Development and Validation of a Patient-Reported Outcomes Questionnaire for the Assessment of Hereditary Angioedema in Observational Studies

    Nov 1, 2012, 00:00

  • PCN20 Comparative Efficacy and Economic Evaluation of Dacarbazine and Temozolomide in Treatment of Malignant Melanoma in Iran

    Nov 1, 2012, 00:00

  • PHS46 Cost-Effectiveness of a Secondary Prevention Program in Patients With Myocardial Infarction- Results from a Randomised Controlled Trial (Proactive Heart)

    Nov 1, 2012, 00:00

  • PRM83 Comparing Methods of Mixed Treatment Comparisons in Health Economic Models

    Nov 1, 2012, 00:00

  • PMD84 Telemonitoring After Discharge With Heart Failure - Cost-Effectiveness Modelling of Alternative Service Designs

    Nov 1, 2012, 00:00

  • CE4 Cost-Effectiveness of Dabigatran Compared to Genotype-Guided Warfarin Dosing for Stroke Prophylaxis in Atrial Fibrillation Patients

    Nov 1, 2012, 00:00

  • QL4 The Impact of Disease Information on General Public Preferences for Health States- Comparing Labeling, Disease-Specific, and Adaptation Information

    Nov 1, 2012, 00:00

  • PCN131 Pricing Theory and Reality- The Link Between Outcomes and Price

    Nov 1, 2012, 00:00

  • PCV21 Hospital Based Cost Survey of Acute Coronary Syndrome in South Korea

    Nov 1, 2012, 00:00

  • PIN84 Trends in Prevalence of Antibacterial Drug Use Among Dutch Children From 2005 Until 2010

    Nov 1, 2012, 00:00

  • PHP187 Pharmacovigilance and the Case Study of VIOXX

    Nov 1, 2012, 00:00

  • PHP16 Generic Drug Market Access in Japan

    Nov 1, 2012, 00:00

  • PMH1 Evaluation of Drug-Related Problems in Depressive Patients

    Nov 1, 2012, 00:00

  • PDB36 Glycemic Control and Quality of Life for Patients With Type 2 Diabetes Mellitus in China

    Nov 1, 2012, 00:00

  • PRM91 How Do Patients With Different Conditions Describe Their Pain?

    Nov 1, 2012, 00:00

  • PDB11 A Large-Scale Longitudinal Population-Based Study of Risk Reduction of Cardiovascular Complications in Patients on Bolus Insulin Analogues

    Nov 1, 2012, 00:00

  • PIH1 Pregnancy Outcomes After Maternal Exposure to Topical Corticosteroids- A Population-Based Cohort Study

    Nov 1, 2012, 00:00

  • PHP135 Stakeholders's Views of the Social Insurance Reform in Greece

    Nov 1, 2012, 00:00

  • MO2 Impact of Structural Assumptions on Cost-Effectiveness Outcomes- Towards a Standardized Cost-Effectiveness Model for Adjuvant Breast Cancer Therapies

    Nov 1, 2012, 00:00

  • PHP13 Affordability of Antibacterial Medicines in Iran During 2001-2010

    Nov 1, 2012, 00:00

  • PCV85 Persistence of Patients Treated Hypertensive Medication in PBM With Different Percentages of Financial Subsidy

    Nov 1, 2012, 00:00

  • PRM24 Methods for Analysis of Censored Cost Data

    Nov 1, 2012, 00:00

  • PIN2 Estimating the Additive Effects of Length of Stay on Contracting Clostridium Difficile Infection

    Nov 1, 2012, 00:00

  • MO1 Comprehensive Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Depression

    Nov 1, 2012, 00:00

  • PCV53 Economic Evaluation of a Single Pill Triple Antihypertensive Therapy With Valsartan, Amlodipine, and Hydrochlorothiazide Against Its Dual Components in Greece

    Nov 1, 2012, 00:00

  • PMS5 A Randomized, Placebo Controlled Trial to Compare Safety and Efficacy Between Curcuma Longa Linn Extract [NR-INF-02], Glucosamine Sulphate and Combination of Two in the Treatment of Painful Knee Osteoarthritis

    Nov 1, 2012, 00:00

  • PUK15 Sevelamer in Early Stages Nondialysis-Dependent Chronic Kidney Disease (NDD-CKD) Dominates Calcium Carbonate Through Reduction of Deaths and Hospitalizations

    Nov 1, 2012, 00:00

  • PRM29 Suprapubic Prostatectomy (SP) Versus Transurethral Endoscopic Resection of Prostate (TURP)- Hospitalization Outcomes and Costs of Benign Prostatic Hyperplasia Using a Prublic Database (DATASUS) in Brazil

    Nov 1, 2012, 00:00

  • PMD4 Cardiovascular Risk Prevalence in High Risk Primary Care Patients Not Treated With Lipid-Lowering Treatment in France, Results of an Online Study

    Nov 1, 2012, 00:00

  • PRM150 Latent Transition Analysis as a Tool for Analysing Clinical Data

    Nov 1, 2012, 00:00

  • PHP110 Real-World Diagnosis and Treatment Patterns of Iron Deficiency Anemia in China

    Nov 1, 2012, 00:00

  • CV3 Outcomes and Costs of Concomitant Aortic Valve Replacements Associated With a New Sutureless and Collapsed Valve in Italy, France, Germany, and the UK

    Nov 1, 2012, 00:00

  • VA1 A European-Wide Study on the Role of Streptococcus Pneumoniae in Community-Acquired Pneumonia among Adults- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PCN42 Cost of Prostate Image-Guided Radiation Therapy- Results from a Randomized Trial

    Nov 1, 2012, 00:00

  • PMD66 Health-Economic Analysis of the Systematic Use of Single-Hand Secured Huber Needles (Positive-Pressure) in French Hospitals

    Nov 1, 2012, 00:00

  • PHP53 Identification of Factors Affecting the Medicine Expenditures in Public Hospital in Malaysia

    Nov 1, 2012, 00:00

  • PRM4 QALY and Productivity Loss- Empirical Evidence for “Double Counting”

    Nov 1, 2012, 00:00

  • PRS6 Prevalence of Selected Conditions in Russia Across Sources

    Nov 1, 2012, 00:00

  • PHP54 Chemical Drug Price Index Study

    Nov 1, 2012, 00:00

  • PND38 Cost Minimization Analysis of Fingolimod Versus Natalizumab in the Second-Line Treatment of Remittent-Recurrent Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PCV31 Cost-Effectiveness of Apixaban Versus Enoxaparin for the Prevention of Postsurgical Venous Thromboembolism in Korea

    Nov 1, 2012, 00:00

  • PHP93 Development of Biosimilar Mark in EU-5 and USA

    Nov 1, 2012, 00:00

  • PND34 Long-Term Effects on Costs and Quality Adjusted Life Years of Patients With Relapsing-Remitting Multiple Sclerosis Treated With Laquinimod- Results Based on the Allegro and Bravo Trials

    Nov 1, 2012, 00:00

  • PSY34 Understanding Disease Presentation and Patient-Reported and Economic Impact of Herpes Zoster (HZ) and Post-Herpetic Neuralgia (PHN)- Findings From the Zoster Quality of Life (ZQOL) Study

    Nov 1, 2012, 00:00

  • PCV37 VIP Study- Incremental Cost During Hospitalization After Total Knee and Hip Arthroplasty in Brazilian Health Care Services

    Nov 1, 2012, 00:00

  • PSS1 Nicotine as a Indicator of Tobacco Exposure and its Effect on Oral Health

    Nov 1, 2012, 00:00

  • PMS1 Irrational Use of Steroids- A Warning for the Health Care System

    Nov 1, 2012, 00:00

  • PRM178 Excel to Mobile- The Method for Automated Migration of Excel-Based Markov Models to Modern Software Platforms

    Nov 1, 2012, 00:00

  • PMH4 Mirror Image Studies of Risperidone Long-Acting Injection for Chronic Schizophrenia and Schizoaffective Disorder

    Nov 1, 2012, 00:00

  • PRM34 The Copyright of Translations of PRO Instruments- The Case of Instruments Used in Lung Diseases

    Nov 1, 2012, 00:00

  • PIN4 The Impact of Pharmacist-Led Antimicrobial Stewardship in Intensive Care Units in a Regional Hospital in Taiwan

    Nov 1, 2012, 00:00

  • PCN66 Cost-Effectiveness of Denosumab Versus Zoledronic Acid for Skeletal-Related Event (SRE) Reduction in Bone-Metastatic Prostate Cancer (mPC) in the UK

    Nov 1, 2012, 00:00

  • PRS13 Variation of Cost of Chronic Obstructive Lung Disease in Adults in Germany- A Systematic Review

    Nov 1, 2012, 00:00

  • PHP36 Comparing Oral 5-Aminosalicylic Acid Treatment Persistence and Adherence in Patients with Ulcerative Colitis in the United States

    Nov 1, 2012, 00:00

  • PMS69 Key Drivers for Pricing and Reimbursement for Biologic Drugs in France

    Nov 1, 2012, 00:00

  • PMH2 Value of Agomelatine in the Treatment of Depressive Disorders in Thailand

    Nov 1, 2012, 00:00

  • PRM48 The Half-Cycle “Correction”- How Much of a Correction is it?

    Nov 1, 2012, 00:00

  • PHS7 Prevalence and Cost of Illness of Specific Conditions in a Commercially Insured United States Population

    Nov 1, 2012, 00:00

  • PHS58 Change in Health-Related Quality of Life After Occpational Therapy in Community-Dwelling Dependent Elderly- A Randomised Controled Trial

    Nov 1, 2012, 00:00

  • PCV4 Comparative Effectiveness Research of Fondaparinux and Enoxaparin in St-Elevated Acute Coronary Syndrome Patients Receiving Fibrinolytic Therapy- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PCV100 Comparison of Health-Related Work Impairment in Russian Patients with US and 5EU

    Nov 1, 2012, 00:00

  • PRS11 Assessment of Knowledge About Tuberculosis Among Libyan and Non Libyan Populations in North East Libya

    Nov 1, 2012, 00:00

  • PHP26 Consumption of Antidiabetics in Serbia in 2010- A Comparison with Croatia and Denmark

    Nov 1, 2012, 00:00

  • PND1 Prescribing Patterns of Z-Drugs Among Geriatric Patients in a 2000-Bed Medical Center in Taiwan

    Nov 1, 2012, 00:00

  • PHS89 How Can We Measure the Impact of Clinical Pharmacy Interventions? A Retrospective Drug Cost Analysis

    Nov 1, 2012, 00:00

  • PHP150 Searching for a Threshold in Hungary

    Nov 1, 2012, 00:00

  • PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes Based on the Plato Trial- A Singapore Health Care Perspective

    Nov 1, 2012, 00:00

  • MO3 Lessons Learned From a Cross-Validation Between a Discrete-Event Simulation Model and a Markov Model for Personalized Breast Cancer Treatment

    Nov 1, 2012, 00:00

  • PDB7 Network Meta-Analysis of Fixed Dose Combination Therapies for the First-Line Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PHP205 Primary Care Transformation As a Solution to the Epidemic of Chronic Diseases

    Nov 1, 2012, 00:00

  • PGI6 Adherence to 5-Aminosalicylic Acid (5-ASA) Therapy for Ulcerative Colitis (UC)- Impact on Health Care Costs

    Nov 1, 2012, 00:00

  • PHS19 Macro-Costing Analysis of Hospital Stay in Heart Failure Patients in Turkish Setting

    Nov 1, 2012, 00:00

  • PHP81 Factors Influencing Interprofessional Collaboration- A Literature Review from 2004-2011

    Nov 1, 2012, 00:00

  • PSY39 Validation of the Lupus Impact Tracker (LIT), a Patient-Reported Outcome (PRO) Tool, in a Prospective Multicenter Longitudinal Study of Systemic Lupus Erythematosus (SLE) Patients

    Nov 1, 2012, 00:00

  • CN3 Cost-Effectivessness Analysis of Treatments in Adult Cancer Patients With Low Risk Febrile Neutropenia in Thailand

    Nov 1, 2012, 00:00

  • PCN83 Cost Effectiveness Analysis in the Veneto Region of Cabazitaxel Versus Mitoxantrone in Patients with Metastatic Hormone Refractory Prostate Cancer, Previously Treated With a Docetaxel Containing Regimen

    Nov 1, 2012, 00:00

  • PMS61 Health-Related Quality of Life After Vertebral Fracture- Differences Between the EQ-5D and Time-Trade-Off Instruments

    Nov 1, 2012, 00:00

  • PSY28 Cost-Effectiveness of Febuxostat in Managing Hyperuricemia in Gout Patients in Spain

    Nov 1, 2012, 00:00

  • ISPOR 5TH Asia-Pacific Conference Research Abstracts Author Index

    Nov 1, 2012, 00:00

  • PGI8 Second and Third Generation FVIII Treatment Resources Consumption Break-Even Point- The Pass Study Results

    Nov 1, 2012, 00:00

  • PRM141 Combining an Ordered Logit Model With Individual Patient-Level Data to Robustly Estimate Within-Category Visual Acuity Starting Distributions- An Innovative Modeling Approach in the Case of Vitreomacular Traction

    Nov 1, 2012, 00:00

  • PRM103 Estimating Health Related Quality in Type 2 Diabetic Patients Receiving Polytherapy With EQ5D-5L Questionnaire

    Nov 1, 2012, 00:00

  • PHS28 The Cost of Management of Patients With Atrial Fibrillation - An Observational Study in UK NHS Primary Care

    Nov 1, 2012, 00:00

  • PND12 A Cost-Effectiveness Analysis of Self-Administrated Injection of Sumatriptan Succinate for Patients With Severe Migraine in Japan Setting

    Nov 1, 2012, 00:00

  • CA3 Use of Health Care Administrative Databases to Estimate the Burden of Breast Cancer

    Nov 1, 2012, 00:00

  • PRM111 Pediatric Patient-Reported Outcomes Assessment- A Case Study in Epidermolysis Bullosa

    Nov 1, 2012, 00:00

  • PIN29 Length of Stay and Cost Due to Recurrent Clostridium Difficile Infections (CDI) at a University Hospital in Finland

    Nov 1, 2012, 00:00

  • PDB57 Patients' Preferences for Attributes of Type 2 Diabetes Medications- A Conjoint Analysis

    Nov 1, 2012, 00:00

  • PHP125 An Early Assessment of the German Federal Joint Commission Resolutions of Additional Clinical Benefit

    Nov 1, 2012, 00:00

  • PMH6 Factors Associated with Medical Expenditure for Dementia in South Korea

    Nov 1, 2012, 00:00

  • PIN47 Cost-Effectiveness Analysis of the Primovaccination of Newborns Against Tuberculosis in Slovakia

    Nov 1, 2012, 00:00

  • PIH51 Review of All Products Authorized by the European Medicines Agency from 1995 to 2011 in Regard to Pediatric Investigation Plan Applications

    Nov 1, 2012, 00:00

  • PCV58 The Cost Effectiveness of Amlodipine Valsartan and Hydrochlorothiazide Single Pill Combination in Turkey

    Nov 1, 2012, 00:00

  • PND1 12-Month Clinical Evolution of Moderate Alzheimer'S Disease Patients in Spain- The Evocost Study

    Nov 1, 2012, 00:00

  • PIH44 Contraceptive Utilization in Women Who Had an Abortion- A Canadian Cohort-Study

    Nov 1, 2012, 00:00

  • CN2 How Early-Stage Non-Persistence and Non-Adherence to Adjuvant Hormonal Therapy Associated With Postmenopausal Breast Cancer Mortality in Taiwan

    Nov 1, 2012, 00:00

  • PDB21 Direct Medical Costs of Diabetes-Related Complications in India

    Nov 1, 2012, 00:00

  • DB4 Screening for Diabetic Retinopathy in Hong Kong- Is Inverse Care Law Operating?

    Nov 1, 2012, 00:00

  • PHP88 A Reimbursement Method for the Public Health Centers in Greece

    Nov 1, 2012, 00:00

  • PND43 Cost-Utility Analysis Patients With Low Back Pain After Treatment Intraosseous Blockades

    Nov 1, 2012, 00:00

  • PMD43 Comparison of Actual Costs Versus DRG Revenue of Cervical Arthroplasty in Patients With Degenerative Disc Disease in Germany

    Nov 1, 2012, 00:00

  • PSS3 Medical Resource Use and Associated Costs in Open-Angle Glaucoma in 10 Asia-Pacific Countries

    Nov 1, 2012, 00:00

  • PIN16 Cost-Effectiveness of Rotavirus Immunization in Indonesia Taking Breastfeeding Patterns Into Account

    Nov 1, 2012, 00:00

  • PGI30 Assessment of Practice Patterns and Treatment-Failure Costs Among Patients With Irritable Bowel Syndrome With Constipation- Findings From a Physician Survey Study

    Nov 1, 2012, 00:00

  • PMD26 Cost Effectiveness of HIV Testing in Non-Traditional Settings – the Hints Study

    Nov 1, 2012, 00:00

  • PDB24 Cost Analysis of Adding Pregabalin or Gabapentin to Usual Care in the Management of Community-Treated Patients With Painful Diabetes Peripheral Neuropathy in Spain

    Nov 1, 2012, 00:00

  • PMD37 Forecasting the Prevalence and Economic Burden of Atrial Fibrillation in Selected Countries, 2010-2025

    Nov 1, 2012, 00:00

  • PCV113 The Utilisation of Statins in Slovak Republic

    Nov 1, 2012, 00:00

  • PSY15 Impact of Chronic Immune-Mediated Inflammatory Diseases on Work Productivity- Literature Review

    Nov 1, 2012, 00:00

  • PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis from a Brazilian Private Perspective

    Nov 1, 2012, 00:00

  • PSY37 Patient-Reported Outcome (PRO) Assessments in Systemic Lupus Erythematosus (SLE)

    Nov 1, 2012, 00:00

  • PCV27 Cost-Effectiveness of Left Atrial Appendage Occlusion Device for Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PMS33 Cost-Efficacy Analysis of Biologic Drugs in Combination With DMARDs in Patients With Active Rheumatoid Arthritis and Inadequate Response to Traditional DMARDs in Portugal – A Simplified Approach

    Nov 1, 2012, 00:00

  • PCN34 Relationship Between Progression-Free Survival and Overall Survival in Chronic Lymphocytic Leukemia

    Nov 1, 2012, 00:00

  • DB4 Patient-Reported Hypoglycaemia in Real-World Settings in Seven European Countries

    Nov 1, 2012, 00:00

  • PDB43 Economic Evaluation of Vildagliptin Compared to Glimepiride as Add-on to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Greece

    Nov 1, 2012, 00:00

  • ISPOR 15th Annual European Congress Disclosure Information for Research Presentations

    Nov 1, 2012, 00:00

  • PCV15 A Cost-Effectiveness Analysis Between Amlodipine and Angiotensin II Receptor Blockers in Stroke and Myocardial Infarction Prevention Among Hypertension Patients in China

    Nov 1, 2012, 00:00

  • PCN3 Improvement of the 3rd Generation Colorectal Cancer Gene Chip

    Nov 1, 2012, 00:00

  • PMD77 Contribution of Individual EQ-5D Dimensions to Improved Quality of Life After Balloon Kyphoplasty for Vertebral Compression Fractures

    Nov 1, 2012, 00:00

  • PMD56 Cost-Efectiveness Analysis Comparing the Application or Not of Whole Brain Irradiation Before Stereotectic Radiosurgery for the Treatment of One to Four Brain Metastases, According to Brazilians Third-Party Private Payer's Perspective ...

    Nov 1, 2012, 00:00

  • PHP128 Amnog in Year 2- Insights from Early Benefit Assessments in Germany

    Nov 1, 2012, 00:00

  • PCN86 Cost-Effectiveness Analysis of Abiraterone for the Treatment of Advanced Prostate Cancer Under the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PIN30 Varicella, a Cost of Illness Hungarian Study

    Nov 1, 2012, 00:00

  • PRM41 Designing Patient Registries- A Case-Study Using an Online Interactive Data Analysis Tool

    Nov 1, 2012, 00:00

  • PDB33 Burden of Disease Attributable to Clinical and Subclinical Hypothyroidism in the Spanish Population

    Nov 1, 2012, 00:00

  • PDB2 Epidemiology, Patient Burden and Related Costs of Obesity in India

    Nov 1, 2012, 00:00

  • PA4 Home Dialysis- How High can we go?

    Nov 1, 2012, 00:00

  • PRM165 Validating Health Economic Models- Developing a Methodological Approach

    Nov 1, 2012, 00:00

  • PCV47 Economic Evaluation of Dabigatran for Stroke Prevention Among Patients With Atrial Fibrillation in the Netherlands

    Nov 1, 2012, 00:00

  • PSS13 Cost-Effectiveness of Specialized Treatment Based on Cognitive Behavioural Therapy Versus Usual Care for Tinnitus

    Nov 1, 2012, 00:00

  • CL3 Calibrating Bayesian Multiple Treatment Comparison Meta-Analysis With Multiple Cost-Effectiveness Acceptability Curves

    Nov 1, 2012, 00:00

  • PSS26 Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA)- An Integrated Approach of Outcomes Measurement in Nail Psoriasis

    Nov 1, 2012, 00:00

  • PCN68 Pharmacoeconomic Evaluation of Rituximab as Maintenance Treatment for Relapsed Follicular Lymphoma- Results of a Real-World Population Based Study

    Nov 1, 2012, 00:00

  • PCN54 Economic Burden Associated With Pancreatic Cancer in Europe

    Nov 1, 2012, 00:00

  • PSU28 Retrospective Analysis of Liver Transplantation in Brazil

    Nov 1, 2012, 00:00

  • CA1 Discordant Diagnoses in Sarcoma, GIST and Desmoide Tumour in Fran Results From the Network RREPS

    Nov 1, 2012, 00:00

  • PRM114 The Challenge of Translating the Picture Naming Subtest of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    Nov 1, 2012, 00:00

  • PMD19 Budget Impact Analysis of Balloon Sinuplasty Versus Classic Functional Endoscopic Sinus Surgery. Using a Budget Impact Model to Identify Country Specific Market Access Strategy

    Nov 1, 2012, 00:00

  • PRS34 Australian New to Therapy Program Improves Tiotropium (Spiriva) Persistence and Compliance

    Nov 1, 2012, 00:00

  • PCV25 A Pharmacoeconomic Assessment of Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • PCV13 Perceptions of Health During Pregnancy Increase the Risk of Cardiovascular Disease

    Nov 1, 2012, 00:00

  • PSY30 Cost-Effectiveness of Ustekinumab in the Management of Moderate-to-Severe Plaque Psoriasis in Mexico

    Nov 1, 2012, 00:00

  • PHP37 Prescription Switching from Angiotensin-Converting Enzyme Inhibitors to Angiotensin Receptor Blockers in Taiwan

    Nov 1, 2012, 00:00

  • PRM143 Cluster Analysis and Principal Component Analysis to Assess the Variability of Data in Cost Evaluations- Methods and Applications in Oncology

    Nov 1, 2012, 00:00

  • PSS9 Cost of Blindness and Visual Impairment in Slovakia

    Nov 1, 2012, 00:00

  • PHP35 Is There a Difference in Prescription Medication Utilization Between Aged Adults with and Without Disability in the United States?

    Nov 1, 2012, 00:00

  • PND2 Effect of Cognitive Behavioural Therapy in Multiple Sclerosis Fatigue- A Systematic Review of Randomised Controlled Trials

    Nov 1, 2012, 00:00

  • PRM175 Identification and Translation of Culturally Bound Terms in Patient Reported Outcome Measures

    Nov 1, 2012, 00:00

  • PND25 Burden of Spina Bifida (SB) in Germany - the Characteristics of SB Population

    Nov 1, 2012, 00:00

  • PHS54 Use of Health Care Administrative Databases to Estimate the Health Care Burden of Bone or Bone Marrow Metastatic Deases in Breast Cancer Patients- A Population-Based Study

    Nov 1, 2012, 00:00

  • PR3 Drivers of Pricing and Market Access Decisions - Examples in Selected Countries

    Nov 1, 2012, 00:00

  • PHP4 Financial Penalties for Improving Drug Adherence

    Nov 1, 2012, 00:00

  • PHP199 The Impact of the German Pharmaceutical Market Reorganisation Act (AMNOG) on the German Reference Price Market – Trends Two Years After the Introduction of the AMNOG

    Nov 1, 2012, 00:00

  • PRM1 What is the Evidence on Using Selected Types of Sutures for Abdominal Surgery – Novel Approach to Create Dynamic Tool for Colleting and Reviewing Available Data

    Nov 1, 2012, 00:00

  • PIN78 Treatment Preference Attributes Among Primary Immunodeficiency Patients and Caregivers Receiving Immunoglobulin Therapy

    Nov 1, 2012, 00:00

  • PRM173 On the Probability of Intertemporal Indifference

    Nov 1, 2012, 00:00

  • PRM22 Testing the Equivalence of the Label Wording for EQ-5D-5L Response Options Across Different Languages in Singapore

    Nov 1, 2012, 00:00

  • PSY17 Estimating the Direct Costs of Patients Treated With Eltrombopag in the French Setting

    Nov 1, 2012, 00:00

  • PGI3 Treatment of Chronic Hepatitis C Genotype 1 in Poland – Real-Life Data

    Nov 1, 2012, 00:00

  • PHP180 Multiple Correspondence Analysis to Understand the Role of Multiprofessional Team for Shared Decision Making to Implementation in Clinical Practice

    Nov 1, 2012, 00:00

  • PDB12 Role of Chromium in Type-2 Diabetes Therapy- A Systematic Review Study

    Nov 1, 2012, 00:00

  • PMD35 Cost Analysis of an Implantable Loop Recorder, Reveal© XT, for the Diagnosis of Atrial Fibrillation in Patients Who Underwent Cryptogenic Stroke From the Perspective of a Tertiary Spanish Hospital

    Nov 1, 2012, 00:00

  • PMD22 Financial Impact of Adopting Implantable Loop Recorder (ILR) Diagnostics (REVEAL®) for Unexplained Syncope in Portugal- Comparison With Conventional Diagnostic Pathways

    Nov 1, 2012, 00:00

  • PDB3 Epidemiology, Patient Burden and Related Costs of Obesity in China

    Nov 1, 2012, 00:00

  • PRS8 The Effect of Asthma on Health Status, Work Productivity, and Health Care Resource Use in Urban China

    Nov 1, 2012, 00:00

  • PCV44 Economic Evaluation of a Single-Pill Triple Combination With Valsartan, Amlodipine and Hydrochlorothiazide Against Its Dual Components in Greece. The Generic Substitution Case

    Nov 1, 2012, 00:00

  • PIN5 Immune Reconstitution Inflammatory Syndrome (IRIS) Incidence in Patients Starting Antiretroviral Therapy (ART) Eartlier Versus Later During Tuberculosis (TB) Therapy- A Systemic Review and Meta-Analysis of Cohort Sutdies

    Nov 1, 2012, 00:00

  • PHS36 Cost Drivers of Household Treatment of Presumptive Malaria in Home-Based Management of Malaria in Ejisu-Juaben Municipality

    Nov 1, 2012, 00:00

  • PHS78 Impact of Educational Intervention on Case Management of ARI at Community Pharmacies in Islamabad Pakistan

    Nov 1, 2012, 00:00

  • PHS42 Cost-Effectiveness of Infant Vaccination With 10 and 13-Valent Pneumococcal Conjugate Vaccines in the Russian Federation

    Nov 1, 2012, 00:00

  • PGI16 Treatment With Prucalopride for Chronic Constipation Improves the Symptoms and Quality of Life of Patients in China

    Nov 1, 2012, 00:00

  • PHP17 Consumption Patterns, Traditional Market and Regulation in the Pharmaceutical Industry. Evidence for Two Therapeutic Groups in Insured Population

    Nov 1, 2012, 00:00

  • PRM5 Systematic Review of Cost-Utility Analyses in Asia

    Nov 1, 2012, 00:00

  • PND3 Relapses Requiring Intravenous Steroids and Multiple Sclerosis-Related Hospitalizations- Findings From the Phase 3 Define and Confirm Studies

    Nov 1, 2012, 00:00

  • PSY31 Association Between Teriparatide Adherence and Health Care Utilization and Costs in Real World United States Hip Fracture Patients

    Nov 1, 2012, 00:00

  • PMH46 Determinants of Health-Related Quality of Life in Japanese Patients With Chronic Schizophrenia

    Nov 1, 2012, 00:00

  • PRM62 Time-Dependency for Treatment Sequences- A Case-Example in Epilepsy

    Nov 1, 2012, 00:00

  • PRM140 An Applied Comparison of Meta-Analysis Techniques Using Bacille Calmette Guerin Vaccine Studies

    Nov 1, 2012, 00:00

  • PIN8 A Preliminary Economical Analysis Based on the Early Impact Observed on Genital Warts Burden Reduction Following Quadrivalent HPV Vaccination in Belgium

    Nov 1, 2012, 00:00

  • PIN68 Cost-Minimization Analysis of Caspofungin Versus Liposomal Amphotericin B for the Treatment of Febrile, Neutropenic Patients With a Presumed Fungal Infection in the Netherlands

    Nov 1, 2012, 00:00

  • PMD64 Can Molecular Allergology Improve Allergen-Specific Immunotherapy Adherence and Patient Quality of Life in a Complex Pollen Area?

    Nov 1, 2012, 00:00

  • PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving Chemotherapy

    Nov 1, 2012, 00:00

  • PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-Up

    Nov 1, 2012, 00:00

  • PSU30 Effects of Different Clinical Practices of Laparoscopic Surgery for Endometriosis Treatment on Cost of Therapy

    Nov 1, 2012, 00:00

  • PHP55 Perception Towards Health Promotion Activities- Findings from a Cross Sectional Survey Among Urban Poor Population in the State of Penang, Malaysia

    Nov 1, 2012, 00:00

  • PHS81 Health Care Organizations/Services Clustering- Comparison of Several Techniques Using UK Data

    Nov 1, 2012, 00:00

  • PIN83 National Immunization Technical Advisory Group (NITAG) Decision-Making Process for Vaccine Recommendation- Overview and Analysis

    Nov 1, 2012, 00:00

  • PMD81 Evaluation of Product Wastage From Modern Human Growth Hormone Administration Devices

    Nov 1, 2012, 00:00

  • PHP107 Observations of Hepatocellular Carcinoma (HCC) Management Patterns from the Global HCC Bridge Study- An Interim Analysis of HCC Burden of Illness in the Asia-Pacific (AP) Cohort

    Nov 1, 2012, 00:00

  • PSY42 Effectiveness and Safety of Anti-TNF Agents in Treatment of Moderate to Severe Psoriasis Vulgaris- Results of Work Productivity and Daily Activity Impairment

    Nov 1, 2012, 00:00

  • PRM132 Using Clinical Outcome Assessments and Economic Data to Facilitate Patient Access in Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PDB49 Cost and Health Care Resources Utilization in the Management of Cushing'S Disease- An Analysis Based on the Ramq Database

    Nov 1, 2012, 00:00

  • PHP163 Assessing the Quality of Manufacturers' Searches in NICE Single Technology Appraisals by Evidence Review Groups

    Nov 1, 2012, 00:00

  • PND56 Assessing the Quality of Life in a Spanish Population With Multiple Sclerosis- The Slims Study

    Nov 1, 2012, 00:00

  • PHS73 Willingness of the Health Care Consumers to Pay for Health Care Services – Results from a Contingnet Valuation Study

    Nov 1, 2012, 00:00

  • PRM94 A New Step in the Use of Computer Adaptive Tests for Measuring Quality of Life. Cultural Adaptation and Calibration in Spain of Two Promis Item Banks- Pain-Behaviour and Pain-Interference

    Nov 1, 2012, 00:00

  • PND31 Economic Value of Slowing Parkinson's Disease in Germany- Modeling Progression Through Hoehn and Yahr Stages

    Nov 1, 2012, 00:00

  • MA1 Utilization of Disease Modifying Agents in Multiple Sclerosis- Analysis From an Italian Administrative Database

    Nov 1, 2012, 00:00

  • PHP193 Paediatric Use Marketing Authorisation (PUMA)- The Challenges of Cost-Effectiveness Modelling Where Limited Clinical Trial Information is Available

    Nov 1, 2012, 00:00

  • PMD67 The Cost Effectiveness of Platelet Rich Plasma Versus Corticosteroids in the Treatment of Lateral Epicondylitis

    Nov 1, 2012, 00:00

  • PCN120 Quality of Life Among German Patients With Metastatic Castration-Resistant Prostate Cancer

    Nov 1, 2012, 00:00

  • PMS59 Impact of Comorbidities on Measuring Indirect Utility by the Medical Outcomes Study Short Form 6D in Lower-Limb Osteoarthritis

    Nov 1, 2012, 00:00

  • UT1 The Calculation of Quality of Life Utilities for Acute Leukemia- A Comparison Between EQ5D-5L and QlQ-C30

    Nov 1, 2012, 00:00

  • PIN27 Cost Analysis of Voriconazole Versus Liposomal Amphotericin B for Primary Therapy of Invasive Aspergillosis Among Hematologic Patients in Germany

    Nov 1, 2012, 00:00

  • PDB15 A1C Variability is Associated With the Risk of Developing New Diabetes for the Healthy Adults

    Nov 1, 2012, 00:00

  • PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma- A Systematic Review

    Nov 1, 2012, 00:00

  • PHS33 Cost Analysis of Dialysis Practice in Turkey

    Nov 1, 2012, 00:00

  • PMH37 Systematic Review of Health State Utilities in Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2012, 00:00

  • PDB64 The Avoidance of Weight Gain is Important for Oral Type 2 Diabetes Treatments in Sweden and Germany- A Patient Preference Study

    Nov 1, 2012, 00:00

  • PSY38 Spontaneous and Probed Disease-Defining Concepts Identified Through Concept Elicitation Interviews in Chronic Low Back Pain

    Nov 1, 2012, 00:00

  • PCN11 Decreased Risk of Prostate Cancer in Type 2 Diabetes Patients- A Meta-Analysis of Cohort Studies

    Nov 1, 2012, 00:00

  • PHP64 Analyzing the Annual Adverse Drug Reactions at a Regional Teaching Hospital of Southern Taiwan

    Nov 1, 2012, 00:00

  • PMS40 Cost-Effectiveness of Denosumab for the Treatment of Male Osteoporosis (MOP) in the Elderly in Sweden

    Nov 1, 2012, 00:00

  • PCV30 Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, Pentoxifylline and Inositol Nicotinate for the Treatment of Intermittent Claudication in People with Peripheral Arterial Disease in the Uk

    Nov 1, 2012, 00:00

  • PMH12 Are Disease Related Costs of Care for Major Depression in Germany Overestimated? – Using Claims Data to Assess the Influence of Disease Severity and Comorbidity

    Nov 1, 2012, 00:00

  • PRM52 Minimum Run-Time Requirements to Reduce Monte Carlo Error in Stochastic Simulations

    Nov 1, 2012, 00:00

  • PHS32 Determination of the Annual Health Insurance Cost of Outpatient Care Physiotherapy Services for Trauma Patients

    Nov 1, 2012, 00:00

  • PDB60 Preliminary Results on the Reliability and Validity of the Worry Subscale of the Hypoglycaemic Fear Survey-II for Assessing the Impact of Fear for Hypoglycemia on the Health-Related Quality of Life of Type 2 Diabetes Mellitus Patients ...

    Nov 1, 2012, 00:00

  • PMD20 Budget Impact of Drug Eluting Balloons for Intermittent Claudication From Superficial Femoral Artery Disease in the United States Health Care System

    Nov 1, 2012, 00:00

  • PGI37 Finalisation and Psychometric Validation of a new Questionnaire Measuring Patient Satisfaction With Anti-TNF Treatments in Severe Crohn's Disease

    Nov 1, 2012, 00:00

  • PCN130 Role of the Health Care Payment System on the Patient Access to Oral Anticancer Drugs- A Comparison of French and North American Situations

    Nov 1, 2012, 00:00

  • PMS4 Comparing the Efficacy and Safety of Biologics for the Treatment of Rheumatoid Arthritis Patients- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PRM47 Cost-Effectiveness Uncertainty Analysis Methods- A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information

    Nov 1, 2012, 00:00

  • PRM40 Efficacy of Liraglutide Compared to Exenatide and Insulin Glargine in Patients With Diabetes Type 2- A Meta-Analysis

    Nov 1, 2012, 00:00

  • CV4 Association Between Knowledge and Health Related Quality of Life? Is Patient Education Always Beneficial?

    Nov 1, 2012, 00:00

  • PMS26 Assessment of the Burden of Rheumatoid Arthritis in Fran Analysis of a National Representative Claim Database

    Nov 1, 2012, 00:00

  • PMH20 Metabolic Consequences and Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder

    Nov 1, 2012, 00:00

  • PHP82 Health Care Utilization Research in Germany- Characterization of the Nordbaden Database

    Nov 1, 2012, 00:00

  • PMH29 Cost Effectiveness of Quetiapine Extended Release Compared With Quetiapine Immediate Release in Schizophrenic Patients in Mexico

    Nov 1, 2012, 00:00

  • PSY2 Preliminary Validation of Collect Scale- A Co-Morbidity Assessment Tool for Patients With Chronic Lymphocytic Leukaemia

    Nov 1, 2012, 00:00

  • PCV35 Correlation Among Pre-Operative Conditions, Waiting Time and Outcome of Elective Patients in Cabg Waiting List in Harapan Kita Hospital 2011

    Nov 1, 2012, 00:00

  • PSU19 Does the Novel Renal Marker NGAL (Neutrophil Gelatinase-Associated Lipocalin) Result in Cost Savings in Patients With Renal Impairment Following Cardiac Surgery?

    Nov 1, 2012, 00:00

  • PIH8 Comparative Pharmacoeconomic Study of Disposable and Reusable Gowns and Drapes

    Nov 1, 2012, 00:00

  • PCN149 Uncertainty Regarding NICE's End-of-Life Small Patient Population Criteria

    Nov 1, 2012, 00:00

  • PRS2 Meta-Analysis of the Effects of Theophylline on Kidney Function in Neonates With Perinatal Asphyxia

    Nov 1, 2012, 00:00

  • PCN1 Use of the 5-HT3-RA Antiemetics in the Prevention and Treatment of Radiation Induced Nausea and Vomiting

    Nov 1, 2012, 00:00

  • PHP35 Systematic Review of Key Issues in Endoscope Reprocessing – Guideline Adherence, Health Outcomes and Resource Use

    Nov 1, 2012, 00:00

  • PCN28 A Feasibility Study on Applying Preference-Based Quality-of-Life Measures in Chronic Myeloid Leukemia Outpatients Treated With Imatinab in Taiwan

    Nov 1, 2012, 00:00

  • PHP9 Drug Pricing in Bosnia and Herzegovina

    Nov 1, 2012, 00:00

  • PRM87 Cross-Cultural Validation of the Huntington Quality of Life Instrument in Spain

    Nov 1, 2012, 00:00

  • PGI12 Cost of Disease Related Malnutrition in Croatia – a Hidden Cost in the Health Care Closet Wants out

    Nov 1, 2012, 00:00

  • PRM139 Including Patients in Multiple Groups and Multiple Times in the Same Group in Longitudinal Observational Research- A Cystic Fibrosis Example

    Nov 1, 2012, 00:00

  • PND50 Estimation of the Effect of Dalfampridine Extended Release on Health Utility in Patients With Multiple Sclerosis Using Two Equations for Mapping the MSWS-12 to the EQ-5D

    Nov 1, 2012, 00:00

  • UT3 Estimating Preference-Based Index from Cancer-Specific Quality of Life Measures for Use in Cost-Utility-Analysis

    Nov 1, 2012, 00:00

  • PSY3 Disease Activity Indices (DAIS) in Systemic Lupus Erythematosus (SLE)

    Nov 1, 2012, 00:00

  • PMD24 Economical Aspects of the Reimbursement of Extracorporeal Photopheresis (ECP) in Treatment of Patients With Graft-Versus-Host Disease (GvHD) After Allogeneic Hematopoietic Cell Transplantation (HCT) Who are Refractory to Steroid Treat ...

    Nov 1, 2012, 00:00

  • PSS25 Validation of the Patient Benefit Index (PBI) for the Assessment of Patient-Defined Benefit in the Treatment of Psoriasis

    Nov 1, 2012, 00:00

  • PIH28 The Project Sincope in Triveneto (PROSIT) Study. A Multicenter Study Regarding Syncope Management in an Italian Region

    Nov 1, 2012, 00:00

  • PMS72 Adherence and Change of Opioid Use After Initiating Duloxetine or Celecoxib Among Patients With Osteoarthritis

    Nov 1, 2012, 00:00

  • PRM100 Converting EORTC QOl-C30 Scores to Utility Values- Is it Plausible?

    Nov 1, 2012, 00:00

  • PIN9 A Multi-Center, Retrospective, Chart Review Study to Compare Direct Health Care Costs of Treatment Experienced Patients With HV/AIDS Before and After Triple Class Failure in Thailand

    Nov 1, 2012, 00:00

  • PCN134 Expenditures and Availability of Orphan Drugs in the Czech Republic- Seven Year Experience (2004 – 2010)

    Nov 1, 2012, 00:00

  • PDB17 Systematic Review of Early Life Determinants of Metabolic Syndrome and Diabetes Mellitus in Bangladesh, India and Pakistan

    Nov 1, 2012, 00:00

  • PHP95 Factors Associated with Physician Participation in a National Continuing Medical Education Program

    Nov 1, 2012, 00:00

  • PCN129 Emerging Market Access Trends- Pricing and Coverage of Targeted Cancer Therapies in Russia (2011-2012)

    Nov 1, 2012, 00:00

  • PHS84 Analyzing Pharmaceutical Expenditure in GreeUnwinding Ariadne's Clue

    Nov 1, 2012, 00:00

  • PHP122 The Use of Quantitative and Qualitative Criteria for Making Drug Funding Decisions

    Nov 1, 2012, 00:00

  • PMS71 Utilization of Duloxetine and Celecoxib in Osteoarthritis Patients

    Nov 1, 2012, 00:00

  • PIN10 Fourth Year Post-Rotavirus Vaccination in Belgium- Decrease of Rotavirus-Positive Stool Samples in Hospitalised Children

    Nov 1, 2012, 00:00

  • PCN31 Treatments Pattern and Outcomes of Ovarian Cancer Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PSS6 Health Economic Evaluation of Preservative-Free Tafluprost Versus Preserved Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension (OH)

    Nov 1, 2012, 00:00

  • PHP174 Physical Activity Matters- The Associations Between Body Mass Index, Physical Activity and Health-Realted Quality-of-Life Trajectories Over 10 Years

    Nov 1, 2012, 00:00

  • PIH50 Trends in Post-Marketing Commitments Related to Pregnancy and Lactation

    Nov 1, 2012, 00:00

  • PIN39 A Cost Consequence Analysis of a Quadrivalent Meningococcal Vaccine (MenACWY-TT) in Canada

    Nov 1, 2012, 00:00

  • PND14 Characteristics of Multiple Sclerosis Patients With High Relapse Rate Using a Claims Database

    Nov 1, 2012, 00:00

  • DB1 Assessing the Relationship Between the Effect of Glycemic Control and Avoided Symptomatic Hypoglycemia on Quality of Life in the Management of Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PDB47 Effects of Patient-Reported Non-Severe Hypoglycaemia on Health Care Resource Use and Work-Time Loss in Seven European Countries

    Nov 1, 2012, 00:00

  • PCV49 Economic Evaluation of Rivaroxaban in Stroke Prevention Among Patients With Atrial Fibrillation in Greece

    Nov 1, 2012, 00:00

  • PRS20 Cost-Benefit Analysis for a Treatment of Pulmonary Arterial Hypertension

    Nov 1, 2012, 00:00

  • PUK18 Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Non-Diabetic Advanced Renal Disease – A Dutch Perspective

    Nov 1, 2012, 00:00

  • PCN107 Persistence in First Line Treatment of Metastatic Renal Cell Carcinoma in Routine Care in Germany

    Nov 1, 2012, 00:00

  • PHP92 Stakeholders's Views on Recently Introduced Measures to Promote Generics Consumption in Greece

    Nov 1, 2012, 00:00

  • PCN94 Feasibility of Efficiency Frontier Analysis (EFA) in Metastatic Breast Cancer (mBC) Treatments- A UK Perspective

    Nov 1, 2012, 00:00

  • PHS67 Rasch Model Validation of a Peer Relations Scale for People Treated for Psychoactive Substance Use Disorder

    Nov 1, 2012, 00:00

  • PHP157 To What Extent Does the Federal Joint Committee Follows the Evidence Based Recommendations by IQWiG

    Nov 1, 2012, 00:00

  • PDB65 Impairment of Work Productivity and Daily Activities in Turkish Patients With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PRM28 Assessing the Completeness of Maternity Data Recording in UK Primary and Secondary Care

    Nov 1, 2012, 00:00

  • PRM43 A Systematic Review on the Application of Cardiovascular Risk Prediction Models in Pharmacoeconomics, With a Focus on Primary Prevention

    Nov 1, 2012, 00:00

  • PCN98 Health Outcome Gains and Costs Offset Associated With Everolimus for the Treatment of Hormone-Receptor–Positive (HR+) HER2-Negative (HER2–) Advanced Breast Cancer (ABC)

    Nov 1, 2012, 00:00

  • PRM110 Planning and Executing Qualitative Research With Adolescents in an Orphan Disease

    Nov 1, 2012, 00:00

  • PGI2 Gastroprotective Evaluation of Phyllanthus Emblica in the Patients With Gastric Ulcers

    Nov 1, 2012, 00:00

  • PHP81 Microeconomic Surplus or Convenience in Health Care- Applied Economic Theory in Health Care in Three European Countries

    Nov 1, 2012, 00:00

  • PSY11 Swedish Adaptation of Czech Pharmacoeconomic Comparison of Treatments in Haemophilia Patients With Inhibitors

    Nov 1, 2012, 00:00

  • PHP2 Evaluation and Comparison of Pharmacovigilance Systems in 70 Different Countries for Consumer Reporting of Adverse Drug Reactions

    Nov 1, 2012, 00:00

  • PGI4 Evaluation of the Efficacy and Incontinence Rate of Biomaterials in Comparison to Conservative and Other Interventional Therapies in Treatment of Perianal Fistula. A Meta-Analysis

    Nov 1, 2012, 00:00

  • PSS6 Cost-of-Illness of Chronic Lymphoedema Patients in Hamburg and Suburban Region

    Nov 1, 2012, 00:00

  • PCV121 Relationship Between Primary Care Physicians Profile, Self-Perceived Health and Recommendations to Their Patients

    Nov 1, 2012, 00:00

  • PSY5 Estimating the Prevalence of Fibromyalgia and Its Impacts on Health in Thais- A Community-Survey in Bangkok, Thailand

    Nov 1, 2012, 00:00

  • PSY21 The Disease Burden Among Patients With Psoriasis in China

    Nov 1, 2012, 00:00

  • PIN2 Assessing the Diagnostic Performance of Human Immunodeficiency Virus Type 1 (HIV-1) Tropism Testing Methods- A Systematic Review of Genotypic Sequencing of the Third Hypervariable (V3) Loop and Enhanced-Sensitivity Phenotypic Assay Tec ...

    Nov 1, 2012, 00:00

  • PDB69 Diffusion of New Technologies Post Reimbursement – Monitoring the Use of Liraglutide in Primary Care

    Nov 1, 2012, 00:00

  • PHP12 The Evaluation of Vaccine Refrigerator Temperature Survey Conducted by Primary Care Units of Songkhla Hospital

    Nov 1, 2012, 00:00

  • PDB72 Main Factors Associated to Costs of Type 2 Diabetes Mellitus (DM2) Care in Spain. A Systematic Review of the 2001-2011 Literature

    Nov 1, 2012, 00:00

  • PHP153 Supporting Payers with Collaborative HTA Tools in Making Evidence-Based Decisions- The United States Experience and International Needs in Europe and Globally

    Nov 1, 2012, 00:00

  • PSS33 Treatment Patterns of Biologic Use in Psoriasis Patients in England

    Nov 1, 2012, 00:00

  • PCN91 The Cost-Effectiveness of Trastuzumab Over the Product Life Cycle in Portugal- A Dynamic and Societal Perspective

    Nov 1, 2012, 00:00

  • PND36 Cost-Effectiveness of Different Interferon-Beta Therapies for Relapsing-Remitting and Secondary Progressive Multiple Sclerosis- A Markov Model Based on Long-Term Clinical Data

    Nov 1, 2012, 00:00

  • PIN70 Cost-Effectiveness of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients With Peginterferon Alfa-2A in Italy

    Nov 1, 2012, 00:00

  • PDB14 Characteristics of the Aboriginal People with Diabetes in the South-Western of Ontario, Canada

    Nov 1, 2012, 00:00

  • PIN34 Development of Treatment Costs of Patients Undergoing Remission Induction Chemotherapy- A Historical Comparison Before and After Introduction of Posaconazole Prophylaxis

    Nov 1, 2012, 00:00

  • PRS27 One-Year Cost-Effectiveness of Montelukast in 2-6-Year-Old Children With Mild-Moderate Persistent Asthma in Belarus

    Nov 1, 2012, 00:00

  • PCV51 Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Adult Patients With Non-Valvular Atrial Fibrillation with One or More Risk Factors – A UK Perspective

    Nov 1, 2012, 00:00

  • PHP25 Market Analysis of Antibiotics Consumption in Northern Part of Iran During 2001-2010

    Nov 1, 2012, 00:00

  • PHP183 The Rocky Road to Market Equilibrium – Price Regulation and Entry Liberalization in Portuguese Retail Pharmacy

    Nov 1, 2012, 00:00

  • PHP55 Compulsory Licenses for Non-Communicable Diseases- Implications for Pharmaceutical Pricing in Low-Income Countries

    Nov 1, 2012, 00:00

  • PMD55 Sacral Nerve Modulation (SNM) for the Treatment of Idiopathic Refractory Overactive Bladder- Cost-Effective in the UK Compared to Optimal Medical Therapy, Botulinum Toxin a (BoNT-A) and Percutaneous Tibial Nerve Stimulation (PTNS)

    Nov 1, 2012, 00:00

  • PHP196 Stakeholder Involvement in Health Technology Assessment (HTA) of Novel Medical Devices

    Nov 1, 2012, 00:00

  • PSY12 The Prevalence and Treatment Status of Hemophilia in India, Russia, Taiwan and Turkey- A Systematic Review and Meta Analysis

    Nov 1, 2012, 00:00

  • PCV18 Cardiovascular Risk Assessment Using Framingham Risk Equation in Newly Diagnosed Type 2 Diabetic Indian Patients

    Nov 1, 2012, 00:00

  • PRM7 Increasing Physical Activity in Patients With Chronic Disease- What is the Literature Telling Us?

    Nov 1, 2012, 00:00

  • PHP10 The Margin Between Acquisition Costs and Reimbursement Prices of Generic Drugs (yakkasa) in Japan- Current Status and Determinants

    Nov 1, 2012, 00:00

  • PHP87 Evaluation of Real Life Use of Sugammadex for Decurarization of Neuromuscular Blockade in Surgical Interventions in Belgium

    Nov 1, 2012, 00:00

  • PRM79 Integrating Patient Preferences and Clinical Trial Data in a Bayesian Model for Quantitative Risk-Benefit Assessment

    Nov 1, 2012, 00:00

  • ME3 Censor Adjusted Net Monetary Benefit of Anti-HCV Therapy in the Variety of Real-World Treatment Setting

    Nov 1, 2012, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117 (current)
  • 118
  • 119
  • 120
  • »